News & Articles

Dr. Werner Lanthaler will strengthen FairJourney Biologics’ global position as a highly efficient partner for antibody discovery and development

The knowledge could reduce the risk of severe bowel complications from radiotherapy, heralding a more personalized approach to prostate cancer treatment

Development agreement applies Optimer binders to cancer imaging and therapeutics

The MERCURIUS™ Spheroid DRUG-seq is a novel, extraction-free RNA sequencing library preparation kit built for 3D spheroid models

First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression

Next-generation medium delivers up to 61% higher titers1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines

Enhanced’s 3D multi-omics platform delivers genetically validated targets for common diseases

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, pharma and biotech partners

Additional capabilities for continuous Adeno-Associated Virus (AAV) and Lentivirus (LV) production for consistent quality, performance, and scalability

Learn how Solventum’s scalable chromatographic clarification platform is helping to meet the growing demands of modern bioprocessing

New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior

Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets

Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years

CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF

Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists

As part of our aim to improve our service to scientists and laboratory professionals, we invite you to complete the SelectScience 2025 survey

As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap

Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data

The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept

To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance

Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability